JESSICA SMITH: Open Payments
NPI 1013441484 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 41 payments from 10 companies in 2025. Trend: 2023 $392 · 2024 $914 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $183 |
| Teva Pharmaceuticals USA, Inc. | 8 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $139 |
| Alkermes, Inc. | 6 | $107 |
| Janssen Pharmaceuticals, Inc | 3 | $81 |
| ABBVIE INC. | 5 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Ambu Inc. | 1 | $36 |
| Medtronic, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: COBENFY, CAPLYTA, AUSTEDO XR, ARISTADA, SPRAVATO, VRAYLAR, REXULTI, UZEDY.
Industry payments across CA — which companies pay providers there.
